JPRN-UMIN000028701
Recruiting
未知
Study on the therapeutic efficacy of conventional crude drug products 'Panaparl tablets' comprising of angelica root, cnidium rhizome, peony root, rehmannia root, etc. on cognitive impairment - Study on the therapeutic efficacy of conventional crude drug products 'Panaparl tablets' on cognitive impairment
Arimatsu Medical and Dental Clinic0 sites50 target enrollmentOctober 1, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Mild cognitive impairment and early Alzheimer'
- Sponsor
- Arimatsu Medical and Dental Clinic
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Psychiatric disorders like visual and auditory hallucinations Focal symptoms like hemiparesis and aphasia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Study to compare topical methotrexate and calcipotriol in psoriasisCTRI/2024/01/061431Eras Lucknow Medical College and Hospital
Recruiting
Phase 3
A comparative study between Spasm relieving medications, Clonazepam and Baclofen given orally in spinal cord injury patients.Health Condition 1: S140- Concussion and edema of cervical spinal cordHealth Condition 2: S340- Concussion and edema of lumbar andsacral spinal cordHealth Condition 3: S240- Concussion and edema of thoracic spinal cordHealth Condition 4: S141- Other and unspecified injuries ofcervical spinal cordHealth Condition 5: S241- Other and unspecified injuries ofthoracic spinal cordHealth Condition 6: S341- Other and unspecified injury of lumbar and sacral spinal cordCTRI/2022/12/047966Bharat Pulavarti
Recruiting
Phase 2
Comparison the Therapeutic Results of Conventional and Accelerated Ponseti Method in Children with Idiopathic ClubfootIRCT20180924041120N1Ahvaz University of Medical Sciences60
Active, not recruiting
Phase 1
Study of the efficacy and safety of Lcr Regenerans®_GynoCans.EUCTR2013-002480-26-PLBIOSE234
Active, not recruiting
Phase 1
Study of the efficacy and safety of treatment administered intravaginallyin the treatment of bacterial vaginosis.Bacterial vaginosisMedDRA version: 19.0Level: LLTClassification code 10046960Term: Vaginosis bacterialSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2015-004563-37-PLaboratoires IPRAD PHARMA530